doi: 10.34172/hpp.2020.18 2 ShamoonHDuffyHFleischerNEngelSSaengerPStrelzynMet al
The lack of treatment options for a burgeoning health problem of this magnitude necessitates that new and innovative therapeutic approaches be developed as quickly as possible
A retrospective follow-up found that 87% of the participants receiving BPC-157 injections had significant relief of their knee pain that lasted for at least 6 months to a year (length of the follow-up).[ref] A clinical trial in rats found that taking BPC-157 orally in water significantly helped mytendonitis injuries after surgery
Foraminal spinal stenosis: According to a 2018 study, 87% of participants with mild to moderate stenosis reported improvement in pain levels, and 42% of participants with severe stenosis reported improvement
Regena was the only one with chromatograms, retention times and lab-named COAs published per batch
Heat, moisture, oxygen exposure, light, and repeated warming can still reduce quality over time